Related Experiment Video
Updated: Jun 19, 2026
09:26
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
[The search for new antitumor medicines]
Alicja Klimczak1, Katarzyna Kubiak
1Medical University of Łódź, Faculty of Physiotherapy, Poland. ala_klimczak@o2.pl
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|October 28, 2009
Summary
Platinum (II) complexes are vital in antitumor therapy. Cis-platinum and carboplatin are key chemotherapy drugs, but research seeks new agents with improved therapeutic indices.
Area of Science:
- Oncology
- Medicinal Chemistry
Context:
- Tumor illnesses represent a significant challenge in modern medicine.
- Platinum (II) complexes are a critical class of drugs used in antitumor therapy.
- Cis-platinum, introduced in the 1970s, is still used for ovarian, esophageal, testicular, and neck tumors.
Purpose:
- To review the role of platinum (II) complexes in cancer treatment.
- To highlight the efficacy and toxicity profiles of cis-platinum and carboplatin.
- To emphasize the ongoing search for novel antitumor agents with enhanced therapeutic indices.
Summary:
- Cis-platinum and carboplatin are established platinum (II)-based chemotherapy drugs with similar mechanisms but varying toxicity.
- These agents have been instrumental in treating various cancers, including ovarian, esophageal, testicular, and neck tumors.
- The development of new platinum-based drugs with improved safety and efficacy remains a priority in cancer research.
Impact:
- Advances in platinum-based chemotherapy have significantly improved patient outcomes for several tumor types.
- Understanding the therapeutic index of existing drugs guides the development of next-generation anticancer agents.
- The continuous pursuit of novel antitumor medicines aims to reduce treatment-related toxicities and enhance patient survival rates.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.